5H·

10.01.2025

500 coins for everyone for 3 more days + US government may sell 69,370 Bitcoin worth billions + TSMC beats estimates thanks to NVIDIA + Novo Nordisk expands AI partnership with Valo


500 coins for everyone who shares their Rewind on Instagram and tags us



US government may sell 69,370 Bitcoin $BTC (+2.37%)worth billions - price plummets



TSMC $2330beats estimates thanks to NVIDIA

  • Taiwan Semiconductor Manufacturing Co (TSMC), the world's largest contract manufacturer of semiconductors, reported a jump in revenue in the fourth quarter of 2024 to T$868.42 billion (USD 26.36 billion).
  • The company thus exceeded market estimates of T$853.57 billion (USD 25.90 billion) and confirmed its own forecast at the same time.
  • The increase in sales was largely driven by the growing demand for AI applications.
  • Compared to the same period last year, when sales amounted to USD 19.62 billion, this corresponds to a strong increase of 34.4%.
  • In December alone, TSMC recorded sales of T$278.16 billion, which corresponds to growth of 57.8% compared to the same month last year.
  • TSMC, whose customers include Apple and Nvidia, is benefiting greatly from the global trend towards artificial intelligence.
  • While demand for semiconductors for consumer electronics - such as tablets - slowed down after the pandemic, the boom in AI-based technologies compensated for this decline and strengthened TSMC's market position in the long term.
  • TSMC will present its full fourth quarter results and outlook for the current year on January 16.



Novo Nordisk $NOVO B (+0.08%)expands AI partnership with Valo

  • Valo Health, a US-based technology company, announced on January 8 that it will expand its existing agreement with Novo to develop new treatments for cardiometabolic diseases using AI and personal data.
  • In September 2023, Novo and Valo had already signed an agreement to develop 11 drugs.
  • The expanded agreement now provides for collaboration on the development of up to 20 new treatments for obesity, type 2 diabetes and cardiovascular disease.
  • Last month, one of Novo's drug candidates, CagriSema, showed lower-than-expected weight loss in clinical trials, affecting the company's plans to launch a successor to its popular weight-loss drug Wegovy.
  • Novo is working to develop an even more effective weight-loss drug than Eli Lilly's.
  • Analysts estimate that the market for anti-obesity drugs will reach a volume of 150 billion dollars in the next decade.



Friday: Stock market dates, economic data, quarterly figures



  • ex-dividend of individual stocks
  • Repsol EUR 0.48
  • Iberdrola EUR 0.23
  • Verizon Communications USD 0.68
  • Mastercard 0.76 USD
  • AT&T USD 0.28


  • Quarterly figures / Company dates USA / Asia
  • Untimed: Delta Air Lines quarterly figures


  • Quarterly figures / Company dates Europe
  • 08:00 Sainsbury Q3 sales


Economic data

08:00 DE: Turnover in the service sector October FORECAST: n.a. previous: +0.3% yoy

08:45 FR: Industrial production November PROGNOSE: -0.1% yoy previous: -0.1% yoy | Private consumption November PROGNOSE: +0.1% yoy/-0.2% yoy previous: -0.4% yoy/+0.4% yoy

14:30 US: Labor market data December employment ex agriculture PROGNOSE: +155,000 yoy previous: +227,000 yoy Unemployment rate PROGNOSE: 4.2% previous: 4.2% average hourly earnings PROGNOSE: +0.3% yoy/+4.0% yoy previous: +0.4% yoy/+4.0% yoy

  • 16:00 US: Consumer Sentiment Index Uni Michigan (1st survey) January FORECAST: 74.0 PREVIOUS: 74.0
previw image
20
Join the conversation